Acadia Healthcare (NASDAQ:ACHC) Posts Better

Acadia Healthcare (NASDAQ:ACHC) reported Q2 CY2026 revenue of $865.8 million, flat year on year but above expectations by about 2%, and non-GAAP adjusted EPS of $0.38, down from $0.83 but 9.7% above consensus. The company guided full-year revenue to about $3.43 billion. Shares fell about 1.3% to $32.18 after the report.

Original reporting
Published Jul 28, 2026, 10:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 28, 2026, 10:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Acadia Healthcare (NASDAQ:ACHC) Posts Better — source image
Decision brief

The 30-second read

$ACHCBullishMed
01

Why it matters

Q2 results beat consensus on revenue and adjusted EPS, while full-year revenue guidance is roughly in line with estimates. The article also stresses decelerating growth and weak operating margin history, which can limit multiple expansion.

02

Market read

This is a company-specific earnings-style update with concrete Q2 figures and full-year revenue guidance, plus a stated immediate post-report stock move.

03

What to watch

Traders may want to focus on admissions growth versus pricing consistency and whether cost pressures are easing, since the article flags profitability deterioration over multi-year horizons.

Relevance 7/10Novelty 6/10Timing: after-hours/next-session reaction to Q2 results and full-year revenue outlook

Background

The article frames Acadia Healthcare’s Q2 CY2026 performance versus consensus, then discusses longer-term revenue growth, admissions, and profitability trends.

Company-level read

Ticker impact

$ACHCBullishMedium confidence
Context

Acadia Healthcare reported Q2 CY2026 revenue of $865.8M (flat YoY) and adjusted EPS of $0.38, beating consensus, with full-year revenue guided to about $3.43B.

Expected impact

Near-term reaction likely supported by the beat, but follow-through may be capped by flat YoY revenue and weaker profitability trends described in the article.

Evidence & confidence

The article provides concrete Q2 results and full-year revenue expectation, but it also highlights decelerating growth and declining operating margin, which can temper the market’s enthusiasm.

Market effects

Behavioral health providers may see read-across on demand stability and margin pressure if peers face similar cost-base constraints.

Primarily US healthcare demand and reimbursement dynamics; no specific regional catalyst cited.

Limited, as the company’s operations and guidance are US-focused with no international drivers mentioned.

Counterpoint

The beat may be more about estimate positioning than fundamental improvement, given flat YoY revenue and the article’s emphasis on declining operating margin and EPS.

Key entities

  • Acadia Healthcare

    Behavioral health provider reporting Q2 CY2026 results and full-year revenue expectation.

  • Wall Street consensus

    Analyst estimates used as the benchmark for the reported beat and guidance alignment.

Related articles

$ACHCMedAI 8/10

Acadia Healthcare Q2 Earnings Call Highlights

Acute care: Revenue was $495 million, flat year over year but up 6% after normalizing for supplemental payments. Management cited strong volumes and admissions at existing acute facilities as well as newer joint-venture and de novo locations. Specialty care: Revenue was $134 million, up 4% sequentially from the first quarter. The business experienced the full-quarter impact of the New York Medicaid decision.

$ACHCMedAI 8/10

Acadia Healthcare: Q2 Earnings Snapshot

Acadia Healthcare Co. (ACHC) reported Q2 net income of 12 cents per share and adjusted earnings of 38 cents per share, versus a Zacks mean estimate of 33 cents. Revenue was $865.8 million, above the $844.7 million forecast. Full-year guidance calls for EPS of $1.45 to $1.60 and revenue of $3.4 billion to $3.45 billion.

$ACHCMed

Acadia Healthcare Company, Inc. (ACHC): Results of Operations and Financial Condition

Acadia Healthcare Company, Inc. (ACHC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_994474.htm EXHIBIT 99.1 ex_994474.htm Exhibit 99.1 ACADIA HEALTHCARE ANNOUNCES SECOND QUARTER 2026 RESULTS AND UPDATES FULL YEAR 2026 FINANCIAL AND CASH FLOW GUIDANCE FRANKLIN, Tenn. (July 28, 2026 ) – Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASD

$DTMedAI 8/10

Dynatrace Springs on Q1 Figures

Dynatrace (NYSE: DT) reported Q1 FY2027 results for the quarter ended June 30, 2026. Total ARR was $2,136 million, up 17%. Total revenue rose to $555 million, up 16%. Subscription revenue was $530 million. GAAP operating income was $71 million and non-GAAP $162 million. CEO Rick McConnell cited 41% organic net new ARR growth and accelerating TTM growth.

$DBXMed

Dropbox Shares Decline Despite Earnings Beat as Revenue Growth Disappoints

Dropbox (DBX) shares fell about 5% premarket to around $32.80 after Q2 2026 results. The company reported adjusted EPS of $0.75 vs $0.74 expected and revenue of $631.5M vs about $627M, but revenue rose only 0.9% year over year. Non-GAAP operating margin improved to 39.7%. Paying users reached 18.19M. William Blair upgraded to Market Perform, while consensus remains Sell.